查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417727

人口筛检市场报告：2030 年趋势、预测和竞争分析

Population Screening Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

人群筛检趋势和预测

2024年至2030年，全球人口筛检市场将以5.5%的复合年增长率成长。该市场的主要驱动因素是医生和患者中慢性病盛行率的增加以及对人口筛检计划领域的投资增加。全球人口筛检市场的未来看起来充满希望，大众和高端市场都充满机会。

人口筛检市场洞察

Lucintel 预测，由于用于大规模筛检更多疾病的新检测套组的核准不断增加，硬体设备在预测期内仍将是最大的细分市场。

由于进行全面人群筛检的挑战越来越大，大规模使用将继续占据该市场的很大一部分。

由于该地区政府采取了预防措施，北美在预测期内仍将是最大的地区。

常问问题

Q1.市场成长预测如何？

A1. 2024年至2030年，全球人口筛检市场预期复合年增长率为5.5%。

Q2.影响市场成长的主要驱动因素有哪些？

A2. 该市场的主要驱动因素是医生和患者中慢性病盛行率的增加以及对人口筛检计画部门的投资增加。

Q3.市场的主要细分市场有哪些？

A3. 大众放映市场的未来性充满希望，大众和高端市场都有机会。

Q4.市场上主要企业有哪些？

A4.人群筛检主要企业如下。

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics

Q5.未来最大的细分市场是什么？

A5.Lucintel 预计，由于用于大规模筛检更多疾病的新检测套组的核准不断增加，硬体设备在预测期内仍将是其最大的细分市场。

Q6. 未来五年预计哪个地区将成为最大的市场？

A6. 在预测期内，由于政府的预防措施，北美仍将是最大的地区。

Q7. 可以客製化报告吗？

A7. 是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球人群筛检市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球人口筛检市场趋势（2018-2023）与预测（2024-2030）
  • 按产品分類的全球人口筛检市场
    • 硬体设备
    • 测试/研究
    • 分析/解释
  • 按性别分類的全球人口筛检市场
    • 男性
    • 女士
  • 按类型分類的全球人口筛检市场
    • 大众市场
    • 优质的
  • 按业务分類的全球人口筛检市场
    • 医院
    • 调查机构
    • 诊断实验室

第四章 2018-2030年区域市场趋势及预测分析

  • 全球人口筛检市场（按地区）
  • 北美人口筛检市场
  • 欧洲人口筛检市场
  • 亚太地区人口筛检市场
  • 其他地区人口筛检市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品分類的全球人口筛检市场成长机会
    • 按性别分類的全球人口筛检市场成长机会
    • 按类型分類的全球人口筛检市场成长机会
    • 全球人口筛检市场成长机会（按业务）
    • 按地区分類的全球人口筛检市场成长机会
  • 全球人口筛检市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球人口筛检市场的能力
    • 全球人口筛检市场的合併、收购和合资
    • 认证和许可

第七章主要企业概况

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics
简介目录

Population Screening Trends and Forecast

The future of the global population screening market looks promising with opportunities in the mass and premium markets. The global population screening market grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases among physicians and patients and rising investments in the field of population screening programs.

A more than 150-page report is developed to help in your business decisions.

Population Screening by Segment

The study includes a forecast for the global population screening by product, gender, type, business, and region.

Population Screening Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Hardware Equipment
  • Testing / Lab
  • Analytics / Interpretation

Population Screening Market by Gender [Shipment Analysis by Value from 2018 to 2030]:

  • Male
  • Female

Population Screening Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Mass
  • Premium

Population Screening Market by Business [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Research Institutes
  • Diagnostic Labs

Population Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Population Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies population screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the population screening companies profiled in this report include-

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics

Population Screening Market Insights

Lucintel forecasts that hardware equipment will remain the largest segment over the forecast period due to growing approval of novel test kits foe the population screening of more diseases.

Within this market, mass will remain the larger segment due to increasing challenges in conducting comprehensive population screening.

North America will remain the largest region over the forecast period due to precautionary actions implemented by government in the region.

Features of the Global Population Screening Market

Market Size Estimates: Population screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Population screening market size by various segments, such as by product, gender, type, business, and region in terms of value ($B).

Regional Analysis: Population screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, gender, types, businesses, and regions for the population screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the population screening market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for population screening market?

Answer: The global population screening market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the population screening market?

Answer: The major drivers for this market are growing prevalence of chronic diseases among physicians and patients and rising investments in the field of population screening programs.

Q3. What are the major segments for population screening market?

Answer: The future of the population screening market looks promising with opportunities in the mass and premium markets.

Q4. Who are the key population screening market companies?

Answer: Some of the key population screening companies are as follows.

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics

Q5. Which population screening market segment will be the largest in future?

Answer: Lucintel forecasts that hardware equipment will remain the largest segment over the forecast period due to growing approval of novel test kits foe the population screening of more diseases.

Q6. In population screening market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to precautionary actions implemented by government in the region.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the population screening market by product (hardware equipment, testing / lab, and analytics / interpretation), gender (male and female), type (mass and premium), business (hospitals, research institutes, and diagnostic labs), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Population Screening Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Population Screening Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Population Screening Market by Product
    • 3.3.1: Hardware Equipment
    • 3.3.2: Testing / Lab
    • 3.3.3: Analytics / Interpretation
  • 3.4: Global Population Screening Market by Gender
    • 3.4.1: Male
    • 3.4.2: Female
  • 3.5: Global Population Screening Market by Type
    • 3.5.1: Mass
    • 3.5.2: Premium
  • 3.6: Global Population Screening Market by Business
    • 3.6.1: Hospitals
    • 3.6.2: Research Institutes
    • 3.6.3: Diagnostic Labs

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Population Screening Market by Region
  • 4.2: North American Population Screening Market
    • 4.2.2: North American Population Screening Market by Type: Mass and Premium
  • 4.3: European Population Screening Market
    • 4.3.1: European Population Screening Market by Product: Hardware Equipment, Testing / Lab, and Analytics / Interpretation
    • 4.3.2: European Population Screening Market by Type: Mass and Premium
  • 4.4: APAC Population Screening Market
    • 4.4.1: APAC Population Screening Market by Product: Hardware Equipment, Testing / Lab, and Analytics / Interpretation
    • 4.4.2: APAC Population Screening Market by Type: Mass and Premium
  • 4.5: ROW Population Screening Market
    • 4.5.1: ROW Population Screening Market by Product: Hardware Equipment, Testing / Lab, and Analytics / Interpretation
    • 4.5.2: ROW Population Screening Market by Type: Mass and Premium

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Population Screening Market by Product
    • 6.1.2: Growth Opportunities for the Global Population Screening Market by Gender
    • 6.1.3: Growth Opportunities for the Global Population Screening Market by Type
    • 6.1.4: Growth Opportunities for the Global Population Screening Market by Business
    • 6.1.5: Growth Opportunities for the Global Population Screening Market by Region
  • 6.2: Emerging Trends in the Global Population Screening Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Population Screening Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Population Screening Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Agilent Technologies
  • 7.2: Thermo Fisher Scientific
  • 7.3: QIAGEN
  • 7.4: F. Hoffmann-La Roche
  • 7.5: Quest Diagnostics